Skip to main content

Emerson Electric Co.

corporate_fare Company Profile

Emerson Electric Co.

EMR·NYSE·Manufacturing·CIK 0000032604

Emerson Electric Co. is a global automation company that provides innovative solutions for customers in a wide range of end markets around the world. Through its leading automation portfolio, Emerson helps process, hybrid and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. Sales by geographic destination in 2026 were: the Americas, 52 percent; Asia, Middle East & Africa, 30 percent (China, 9 percent); and Europe, 18 percent. Emerson was incorporated in Missouri in 1890 and has evolved through internal growth and strategic acquisitions. The Company's comprehensive automation portfolio includes intelligent devices, control systems and design and optimization software solutions to support a diverse set of industries and infrastructure, including process industries (such as power, chemical, and energy), hybrid industries (life sciences, metals & mining, food & beverage, pulp & paper, and others), discrete industries (including semiconductor, aerospace & defense, automotive, medical, and packaging) and more. Over the past several years, the Company has taken significant actions to accelerate the transformation of its portfolio. These actions were undertaken to create a cohesive, higher growth, higher margin industrial technology portfolio, and the Company is now a global automation leader serving a diversified set of end markets. The Company's recent portfolio actions include the following transactions (note that all dollars in Item 1 are in millions, except where noted): On March 12, 2025, Emerson completed its purchase of the remaining outstanding shares of common stock of AspenTech not already owned by the Company for approximately $7.2 billion.

Emerson Electric Co. (NYSE:EMR) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 12 items for EMR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for EMR spans 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • Emerson 10-K: FY26 Sales $19.0B, Adjusted EPS $6.59; FY27 Guidance ~$7.25
  • Emerson Tops Q4 Estimates, Lifts Dividend 7%, Sets FY27 Adjusted EPS Guidance Near $7.25
  • Emerson Wins Contract for Europe's First Greenfield SAF Plant
  • Emerson Acquires Glue Inc. to Boost AI-Driven Test & Measurement
  • Emerson Beats Q3 Estimates on 23% Test & Measurement Surge, But Shares Dip 2.4% After Hours

Financial Snapshot

Fiscal year ended September 30, 2026
Revenue
$18.98B
Net Income
$2.69B
Diluted EPS
$4.79
Op. Cash Flow
$3.98B
Free Cash Flow
$3.54B
Gross Profit
$10.13B
Cash & Equivalents
$1.81B
Total Debt
$8.27B
Debt / Equity
0.40×
Net Margin
14.2%
Shares Outstanding
557.3M sh
Source: 10-K · filed 2026-11-09 · accession 0000032604-26-000054

Short Interest & Short Volume

3.22 days to cover

FINRA reported short interest of 9,886,906 shares in EMR as of the October 30, 2026 settlement, a 4.2% increase from the prior period — about 3.2 days to cover at its recent average daily volume. On November 20, 2026, 53.8% of EMR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,886,906 shares as of October 30, 2026
Change vs prior period▲ 4.2%
Days to cover3.22 at avg daily volume of 3,074,981
Daily short volume (FINRA facilities)53.8% of 1,176,146 shares on November 20, 2026
5-day average short volume44.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for EMR, detected from its recent SEC filings.

1 shelf registration

Universal Shelf Registration Filed · No Securities Sold, No Terms Set

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with E →
$153.11 +1.44% today
52-week range · as of 2026-11-09 $122.64 – $172
Market cap
$82.8B
Volume
3.5M (1.2× avg)
3-mo avg 2.9M
Live data · 2026-11-21 16:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed EMR - Latest Insights

EMR
Nov 09, 2026, 4:27 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $169.52
Real-time Price: $153.11 info
Change: -$16.41 (-10%) info
Market Cap: $82.8B info
EMR
Nov 04, 2026, 6:53 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $166.40
Real-time Price: $153.11 info
Change: -$13.29 (-8%) info
Market Cap: $82.8B info
EMR
Sep 15, 2026, 10:36 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $146.88
Real-time Price: $153.11 info
Change: +$6.23 (+4%) info
Market Cap: $82.8B info
EMR
Aug 06, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $156.50
Real-time Price: $153.11 info
Change: -$3.39 (-2%) info
Market Cap: $82.8B info
EMR
Aug 04, 2026, 5:47 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $153.00
Real-time Price: $153.11 info
Change: +$0.110 (+0.07%) info
Market Cap: $82.8B info
EMR
Aug 04, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $155.00
Real-time Price: $153.11 info
Change: -$1.89 (-1%) info
Market Cap: $82.8B info
EMR
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $155.00
Real-time Price: $153.11 info
Change: -$1.89 (-1%) info
Market Cap: $82.8B info
EMR
May 05, 2026, 4:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $135.02
Real-time Price: $153.11 info
Change: +$18.09 (+13%) info
Market Cap: $82.8B info
EMR
May 05, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $136.00
Real-time Price: $153.11 info
Change: +$17.11 (+13%) info
Market Cap: $82.8B info
EMR
May 04, 2026, 4:38 AM EDT
Source: Zawya
Importance Score:
7
Price at Filing: $140.65
Real-time Price: $153.11 info
Change: +$12.46 (+9%) info
Market Cap: $82.8B info
EMR
Apr 21, 2026, 1:04 AM EDT
Source: Zawya
Importance Score:
7
Price at Filing: $147.00
Real-time Price: $153.11 info
Change: +$6.11 (+4%) info
Market Cap: $82.8B info
EMR
Feb 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $150.35
Real-time Price: $153.11 info
Change: +$2.76 (+2%) info
Market Cap: $82.8B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets